Evolution of the Average Target: GoHealth, Inc.

Evolution of the Target Price: GoHealth, Inc.

Changes in Analyst Recommendations: GoHealth, Inc.

91b0eeada379.S6xzHvFuPiQC-e5YXXbdJ4VQ1wC3LkF7VYJCa6IP5ok.D55GbsRXVUFbiNwTBzjuSLI7jzP_ZgcwHfo3HMVc18gR3UVPvSkKCTezhQ~dc7decc0f33179abf6bd8a4d53b4f282
26/11 RBC Cuts Price Target on GoHealth to $5 From $12, Keeps Sector Perform Rating MT
19/11 William Blair Downgrades GoHealth to Market Perform From Outperform MT
28/25/28 RBC Cuts Price Target on GoHealth to $12 From $18, Keeps Sector Perform Rating MT
20/24/20 RBC Cuts Price Target on GoHealth to $13 From $20, Notes 'Diminished Topline Visibility' in Near Term; Sector Perform Kept MT
14/23/14 RBC Raises PT on GoHealth to $20 From $15 After 'Solid' Q2 Results, Says Encompass Gains Momentum Ahead of Annual Enrollment Period; Sector Perform Kept MT
12/23/12 RBC Raises Price Target on GoHealth to $15 From $14, Maintains Sector Perform Rating MT
04/23/04 Credit Suisse Raises GoHealth's Price Target to $8.50 From $7 After Model Update; Keeps Underperform Rating MT
17/23/17 RBC Cuts Price Target on GoHealth to $14 From $15 After Q4 Miss Amid Negative Revenue Lookback Adjustment; Sector Perform Kept MT
23/22/23 Credit Suisse Adjusts GoHealth's Price Target to $7 From $18.75, Retains Underperform Rating MT
26/22/26 RBC Capital Adjusts GoHealth's Price Target to $1 From $2, Maintains Sector Perform Rating MT
16/22/16 Evercore ISI Adjusts GoHealth's Price Target to $1.75 from $4.50, Keeps In Line Rating MT
16/22/16 Morgan Stanley Adjusts GoHealth Price Target to $1 From $3, Maintains Equalweight Rating MT
03/22/03 RBC Downgrades GoHealth to Sector Perform From Outperform, Slashes Price Target to $2 From $10, Citing 'Sea Change in Operating Backdrop' MT
02/22/02 Truist Securities Downgrades GoHealth to Hold from Buy, Lowers Price Target to $2 From $6 MT
18/22/18 Barclays Adjusts Price Target for GoHealth to $3 From $5, Maintains Equalweight Rating MT
07/22/07 Credit Suisse Downgrades GoHealth to Underperform from Neutral, Says Among Potential M&A Targets; Lowers PT to $3 from $6 MT
05/22/05 BofA Securities Double Downgrades GoHealth to Underperform from Buy, Adjusts Price Target to $3.50 from $7.50; Shares Drop 12% MT
05/22/05 Evercore ISI Lowers Price Target for GoHealth to $4.50 From $7.50, Maintains In-Line Rating MT
11/21/11 Morgan Stanley Adjusts Price Target on GoHealth to $5.50 from $13, Keeps Equalweight Rating MT
11/21/11 Truist Lowers Price Target for GoHealth to $6 From $11, Maintains Buy Rating MT
10/21/10 RBC Cuts Price Target on GoHealth to $10 From $17, Citing Sector Rerating, Maintains Outperform Rating MT
09/21/09 Barclays Downgrades GoHealth to Equalweight from Overweight, Adjusts Price Target to $5 from $10 MT
13/21/13 GOHEALTH : Barclays Adjusts GoHealth's Price Target to $10 from $18, Keeps Overweight Rating MT
12/21/12 GOHEALTH : Credit Suisse Downgrades GoHealth to Neutral from Outperform on Q2 EBITDA Miss, Reduced 2021 EBITDA Outlook; Lowers PT to $10 from $18 MT
12/21/12 GOHEALTH : Receives Cut to Price Target From RBC to $17 From $20, Shares Fall Pre-Bell After Q2 EBITDA Miss; Outperform Kept MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+288.89%
+25.19%
+35.71%
+29.36%
+24.77%
+0.77%
+43.3%
+40.28%
+22.86%
+48.39%
Average +55.95%
Weighted average by Cap. +28.38%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.755USD
Average target price
7.700USD
Spread / Average Target
+338.75%
High Price Target
10.00USD
Spread / Highest target
+469.80%
Low Price Target
4.500USD
Spread / Lowest Target
+156.41%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

RBC Capital Markets
William Blair & Co.
Credit Suisse
Morgan Stanley
Evercore ISI
Truist Securities
Barclays
BofA Securities
Raymond James
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.755USD
Average target price
7.700USD
Spread / Average Target
+338.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. GOCO Stock
  4. Consensus GoHealth, Inc.